Glenn R. Larsen is Director at Anika Therapeutics, Inc. (ANIK). They have made 1 open-market trade across 1 company since 2019, most recently 2025-06-20.
CIK 0001633737
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ANIK | 50,258 | $1.0M |
Shares reported on the most recent Form 4, priced at the 2025-06-24 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ANIK | SELL | 2019-08-28 | 2019-08-30 | $57.21 | $498K | -2.9% | -2.8% | +2.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.